REGENXBIO Interim Data Update from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery; Hawaiian Eye and Retina 2024 Jan 16, 2024 at 4:30 PM EST Click here for webcast Supporting Materials REGENXBIO Interim Data Update from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery Presentation; Hawaiian Eye and Retina 2024 990 KB
REGENXBIO Interim Data Update from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery Presentation; Hawaiian Eye and Retina 2024 990 KB
